Atlas Trials

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

Clinical trial NCT03493646 · COMPLETED

Trial details

NCT number
NCT03493646
Sponsor
Kirby Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Start date
2018-05-18
Primary completion
2020-09-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.